Similar to other metal-on-metal hip products on the market, the ASR hip replacement systems have been surrounded with controversies that describe their safety on a less favorable light. They have been the subject of numerous studies and thousands of adverse event reports, most of which link the ASR hips to early implant failure and complications related to metal toxicity. Health problems allegedly stemming from the ASR hip replacement systems have also drawn a series of lawsuits against DePuy and its parent company J&J.
Considered as one of the country’s most prominent product recalls, the so-called DePuy ASR hip replacement recall reportedly affects more than 93,000 implants distributed internationally, including about 37,000 units sold in the US alone, according to online media reports. Studies have also shown that these devices have been associated with failure rates greater than those of other similar hip implants on the market. Patients who may have received these implants are recommended to remain on the lookout for the following symptoms of a potentially failing implant: hip pain,swelling, joint dislocation, hip discomfort, limited mobility, or bone loss due to inflammation in the affected area.
With or without these symptoms, however, DePuy ASR hip recipients are still encouraged to submit themselves to a blood test which could analyze the levels of metallic debris that may have accumulated in the area surrounding the hip. Medical experts point out that increased levels of these particles could be an indication of a possible hip implant failure. As these minute metal particles build up, they may also be distributed through the blood, leaving hip implant recipients highly susceptible to health risks associated with metal poisoning, including persistent pain, pseudotumors, tissue death, or recurring infections. In most cases, recipients who have experienced hip implant failure have been subjected to early revision surgery to remove and replace their implants.
0 comments:
Post a Comment